Revising Adult RSV Policy: US CDC Moves Toward Risk-Based Vaccine Recommendation

 
• By Bridget Silverman
RSV Vaccine
The ACIP work group said to recommend GSK's RSV vaccine for adults age 60-74 at increased risk of severe disease. • Source: Shutterstock

More from Vaccines

More from Pink Sheet